Wits Reproductive Health and HIV Institute

Status:Ongoing
Phase:Demo Project
Principal Investigator(s):Implemented by national partners in each country in collaboration with the World Health Organization, UNAIDS, O’Neill Institute of Georgetown University, London School of Hygiene and Tropical Medicine, Imperial College London
Objective:Aims to assess whether oral PrEP and TasP can be rolled out within a combination prevention and care approach tailored to the needs of 605, both HIV-positive and negative, female sex workers age 18 and older. Study sites include Hillbrow and Waterval Boven.
Prevention Option(s):PrEP
Study Design:
Trial Sponsors: Bill & Melinda Gates Foundation
Start Date
End Date
February 28, 2014
September 30, 2016
Enrollment:0
Age range: ↔ any
Population:Cisgender Women

Wits Reproductive Health and HIV Institute

Status:Planned
Phase:Demo Project
Principal Investigator(s):World Health Organization, UNAIDS, O'Neil Institute of Georgetown University, London School of Hygiene and Tropical Medicine, Imperial College London;
Objective:Aims to assess whether oral PrEP and TasP can be rolled out within a combination prevention and care approach tailored to the needs of 605, both HIV-positive and negative, female sex workers age 18 and older.
Prevention Option(s):PrEP
Study Design:Controlled
Arms and Assigned Interventions
DescriptionAims to assess whether oral PrEP and TasP can be rolled out within a combination prevention and care approach tailored to the needs of 605, both HIV-positive and negative, female sex workers age 18 and older. Study sites include Hillbrow and Waterval Boven.
Mode of DeliveryTablet
ARMsExperimental
Trial Sponsors: Imperial College London, London School of Hygiene and Tropical Medicine, O'Neil Institute of Georgetown University, UNAIDS, WHO
Start Date
End Date
November 1, 2014
none
Enrollment:605
Age range: ↔ any
Population:Cisgender Women, People Living with HIV